Radiology >
Diagnostic Radiology
News, opinions and meeting coverage in radiology.
FDA Orders Black Box Warning for Gadolinium-Based Contrast Agents
ROCKVILLE, Md. -- The FDA today ordered black-box warnings for all gadolinium-based contrast agents for magnetic resonance imaging, detailing an increased risk for nephrogenic systemic fibrosis with kidney-disease patients.
May 23, 2007